The Global Health Body Raises Warning Over Severe Scarcity of Obesity Jabs
Under 10% of patients that would benefit from obesity jabs including Wegovy can access them, warns the global health agency as it issues its initial advice on the drugs.
Given in excess of 1,000,000,000 people worldwide currently obese, it is advocating for more widespread and fairer availability to these injectable treatments.
Per forecasts, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.
"The latest guidance acknowledges that excess weight is a chronic disease that can be addressed with comprehensive and ongoing treatment," said WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and logistical bottlenecks are key barriers to broad availability to the jabs that can help people shift substantial body mass, says the agency.
Skinny Jab Shortage
Despite the present most favorable case, the supply of such drugs would only suffice for around 100 million people – less than 10% of the global need, as stated by the health organization.
The guideline encourages governments and firms to expand availability, through measures including patent sharing.
Exclusive production rights on the active ingredient – the core ingredient of Novo Nordisk's Wegovy – is due to expire in a number of countries in 2026.
How Obesity Jabs Work
The injections replicate a biological compound to slow digestion, reduce hunger and boost the sense of being full so individuals eat less.
People commonly begin shedding pounds in the initial weeks of commencing the once-weekly jabs.
Evidence suggests users may regain a significant portion a year later of discontinuing the treatment, because their typical food cravings return.
Being carrying excess weight elevates your likelihood for contracting diseases, including type 2 diabetes, heart disease, stroke, and certain malignancies.
Obesity impacts people in countries worldwide and was responsible for 3.7 million fatalities worldwide in 2024, according to the WHO.
